The German Cancer Research Center (DKFZ) in Heidelberg has founded the Heidelberg Center for Personalized Oncology (HIPO) in 2011 – an internationally leading center for personalized genome analysis in oncology. The goal of this center is to translate latest research and technologies from the field of functional genomics and systems biology into clinical routine.
The 1st DKFZ-HIPO Symposium on Personalized Oncology focuses on personalized genome analysis efforts. We invite you to join us for the symposium and look forward to meet you in May.
The HIPO Directors:
Peter Lichter, Christof von Kalle und Roland Eils